BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 11526732)

  • 41. Epithelial ovarian tumors in children: a retrospective analysis.
    Morowitz M; Huff D; von Allmen D
    J Pediatr Surg; 2003 Mar; 38(3):331-5; discussion 331-5. PubMed ID: 12632344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical characteristics and prognosis of mucinous tumors of the ovary.
    Kikkawa F; Nawa A; Kajiyama H; Shibata K; Ino K; Nomura S
    Gynecol Oncol; 2006 Oct; 103(1):171-5. PubMed ID: 16546243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transitional cell tumors of the ovary: a comparative clinicopathologic, immunohistochemical, and molecular genetic analysis of Brenner tumors and transitional cell carcinomas.
    Cuatrecasas M; Catasus L; Palacios J; Prat J
    Am J Surg Pathol; 2009 Apr; 33(4):556-67. PubMed ID: 19033864
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
    Borgfeldt C; Iosif C; Måsbäck A
    Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
    Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
    Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study.
    Poncelet C; Fauvet R; Boccara J; Daraï E
    Ann Surg Oncol; 2006 Apr; 13(4):565-71. PubMed ID: 16491337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of borderline tumors of the ovary: state of the art.
    Tropé C; Kaern J
    Semin Oncol; 1998 Jun; 25(3):372-80. PubMed ID: 9633850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors.
    Tinelli R; Malzoni M; Cosentino F; Perone C; Tinelli A; Malvasi A; Cicinelli E
    Fertil Steril; 2009 Aug; 92(2):736-41. PubMed ID: 18793773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ovarian mucinous borderline tumors of intestinal type without intraepithelial carcinoma: are they still tumors of low malignant potential?
    Nomura K; Aizawa S; Hano H
    Pathol Int; 2004 Jun; 54(6):420-4. PubMed ID: 15144401
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Laparoscopic preliminary surgery of ovarian malignancies. Experiences from 127 German gynecologic clinics].
    Kindermann G; Maassen V; Kuhn W
    Geburtshilfe Frauenheilkd; 1995 Dec; 55(12):687-94. PubMed ID: 8582588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers.
    Sakakura C; Hagiwara A; Yamazaki J; Takagi T; Hosokawa K; Shimomura K; Kin S; Nakase Y; Fukuda K; Yamagishi H
    Hepatogastroenterology; 2004; 51(59):1350-3. PubMed ID: 15362750
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ovarian germ cell tumours: a 17-year study in a single unit.
    Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D
    Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors.
    Ren J; Peng Z; Yang K
    Gynecol Oncol; 2008 Aug; 110(2):162-7. PubMed ID: 18495223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors.
    Eltabbakh GH; Shamonki J; Mount SL
    Gynecol Oncol; 2005 Nov; 99(2):309-12. PubMed ID: 16005945
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Malignant ovarian germ cell tumours: a trial of 36 cases].
    Gueye A; Narducci F; Baranzelli MC; Collinet P; Farine O; Fournier C; Vinatier D; Leblanc E
    Gynecol Obstet Fertil; 2007 May; 35(5):406-19. PubMed ID: 17350873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Occult bilateral involvement in stage I epithelial ovarian cancer.
    Benjamin I; Morgan MA; Rubin SC
    Gynecol Oncol; 1999 Mar; 72(3):288-91. PubMed ID: 10053097
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
    Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful pregnancy after conservative surgery for stage IC ovarian cancer with serous borderline tumor on controlateral ovary: a case report.
    Battaglia F; Plotti F; Zullo MA; Panici PB; Plotti G
    Gynecol Oncol; 2006 Mar; 100(3):612-4. PubMed ID: 16249017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.